Linezolid for the Conservative Management of Ventriculoperitoneal Shunt Infection: New Fixed Price Contract

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/1011/30/13

Funding

  • Pfizer Inc.: $61,680.00